NVS

NovartisB

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

85.25

Source

External coverage

Decided

2026-09-08

Novartis Sees Avidity Drug Suffer Third Clinical-Trial Setback

Negative for Novartis as the Avidity treatment failed a late-stage study, following two other clinical-trial setbacks in a week and raising growth concerns.

View event details2 more curated

Sentiment decomposition

+68.1

30-day score

Company-55%

Macro-30%

Pulse-15%

Weekly research-10-day

Company, Macro, and Pulse form the existing 30-day artifact blend. Weekly research is tracked separately for 10 days and can contribute at most 10% of the sentiment pillar when live mode is enabled.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for NVS. Curated events highlight the most material developments impacting this ticker right now.

Check curated events Open full news archive

As of 2026-09-08 • Updated scheduledSource: News desk